Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biomarkers for Psychiatry: The Journey from Fantasy to Fact, a Report of the 2013 CINP Think Tank: Figure 1.
Elizabeth Scarr, Mark J. Millan, Sabine Bahn, et al.
The International Journal of Neuropsychopharmacology (2015) Vol. 18, Iss. 10, pp. pyv042-pyv042
Open Access | Times Cited: 123

Showing 1-25 of 123 citing articles:

Conceptualizing mental disorders as deviations from normative functioning
André F. Marquand, Seyed Mostafa Kia, Mariam Zabihi, et al.
Molecular Psychiatry (2019) Vol. 24, Iss. 10, pp. 1415-1424
Open Access | Times Cited: 339
The C Factor: Cognitive dysfunction as a transdiagnostic dimension in psychopathology
Amitai Abramovitch, Tatiana Short, Avraham Schweiger
Clinical Psychology Review (2021) Vol. 86, pp. 102007-102007
Closed Access | Times Cited: 170
Neurocognitive Functioning in Individuals at Clinical High Risk for Psychosis
Ana Catalán, Gonzalo Salazar de Pablo, Clàudia Aymerich, et al.
JAMA Psychiatry (2021) Vol. 78, Iss. 8, pp. 859-859
Open Access | Times Cited: 160
Peripheral Markers of Depression
Aleksander Nobis, Daniel Zalewski, Napoleon Waszkiewicz
Journal of Clinical Medicine (2020) Vol. 9, Iss. 12, pp. 3793-3793
Open Access | Times Cited: 146
Depression as a risk factor for Alzheimer’s disease: Genes, steroids, cytokines and neurogenesis – What do we need to know?
J. Herbert, Paul J. Lucassen
Frontiers in Neuroendocrinology (2015) Vol. 41, pp. 153-171
Open Access | Times Cited: 136
Role of trophic factors GDNF, IGF-1 and VEGF in major depressive disorder: A comprehensive review of human studies
Ajaykumar N. Sharma, Bruno Fernando Borges da Costa e Silva, Jair C. Soares, et al.
Journal of Affective Disorders (2016) Vol. 197, pp. 9-20
Open Access | Times Cited: 130
Learning from the past and looking to the future: Emerging perspectives for improving the treatment of psychiatric disorders
Mark J. Millan, Guy M. Goodwin, Andreas Meyer‐Lindenberg, et al.
European Neuropsychopharmacology (2015) Vol. 25, Iss. 5, pp. 599-656
Closed Access | Times Cited: 125
Predictive analytics in mental health: applications, guidelines, challenges and perspectives
Tim Hahn, Andrew A. Nierenberg, Susan Whitfield‐Gabrieli
Molecular Psychiatry (2016) Vol. 22, Iss. 1, pp. 37-43
Closed Access | Times Cited: 115
Results of the European Group for the Study of Resistant Depression (GSRD) — basis for further research and clinical practice
Lucie Bartova, Markus Dold, Alexander Kautzky, et al.
The World Journal of Biological Psychiatry (2019) Vol. 20, Iss. 6, pp. 427-448
Closed Access | Times Cited: 115
Animal models in psychiatric research: The RDoC system as a new framework for endophenotype-oriented translational neuroscience
Elmira Anderzhanova, Thomas Kirmeier, Carsten T. Wotjak
Neurobiology of Stress (2017) Vol. 7, pp. 47-56
Open Access | Times Cited: 112
Effect of electroconvulsive therapy on hippocampal and amygdala volumes: systematic review and meta-analysis
Akihiro Takamiya, Jun Ku Chung, Kuo‐ching Liang, et al.
The British Journal of Psychiatry (2018) Vol. 212, Iss. 1, pp. 19-26
Open Access | Times Cited: 111
Endocannabinoid System Components as Potential Biomarkers in Psychiatry
Francisco Navarrete, María S. García‐Gutiérrez, Rosa Jurado‐Barba, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 105
Theranostic Biomarkers for Schizophrenia
Matea Nikolac Perković, Gordana Nedić Erjavec, Dubravka Švob Štrac, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 4, pp. 733-733
Open Access | Times Cited: 99
Biomarkers of Post-COVID Depression
Piotr Lorkiewicz, Napoleon Waszkiewicz
Journal of Clinical Medicine (2021) Vol. 10, Iss. 18, pp. 4142-4142
Open Access | Times Cited: 92
Exploring the role of neuropeptides in depression and anxiety
Tarapati Rana, Tapan Behl, Aayush Sehgal, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2021) Vol. 114, pp. 110478-110478
Closed Access | Times Cited: 82
A growing understanding of the role of muscarinic receptors in the molecular pathology and treatment of schizophrenia
Brian Dean, Geor Bakker, Hiroki R. Ueda, et al.
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access | Times Cited: 26
Serotonin, neural markers, and memory
Alfredo Meneses
Frontiers in Pharmacology (2015) Vol. 6
Open Access | Times Cited: 80
Personalized medicine in psychiatry
Ida Kim Wium‐Andersen, Maj Vinberg, Lars Vedel Kessing, et al.
Nordic Journal of Psychiatry (2016) Vol. 71, Iss. 1, pp. 12-19
Closed Access | Times Cited: 69
Disturbances of sleep quality, timing and structure and their relationship with other neuropsychiatric symptoms in Alzheimer’s disease and schizophrenia: Insights from studies in patient populations and animal models
Raphaëlle Winsky‐Sommerer, Paula de Oliveira, Sally Loomis, et al.
Neuroscience & Biobehavioral Reviews (2018) Vol. 97, pp. 112-137
Open Access | Times Cited: 63
Non-Coding RNA as Novel Players in the Pathophysiology of Schizophrenia
Andrew S. Gibbons, Madhara Udawela, Brian Dean
Non-Coding RNA (2018) Vol. 4, Iss. 2, pp. 11-11
Open Access | Times Cited: 61
Transcranial Direct Current Stimulation Reduces Craving in Substance Use Disorders
Giovanni Martinotti, Matteo Lupi, Chiara Montemitro, et al.
Journal of Ect (2019) Vol. 35, Iss. 3, pp. 207-211
Closed Access | Times Cited: 56
Biological Markers in Anxiety Disorders
Kacper Łoś, Napoleon Waszkiewicz
Journal of Clinical Medicine (2021) Vol. 10, Iss. 8, pp. 1744-1744
Open Access | Times Cited: 55
Alterations in the neuropeptide galanin system in major depressive disorder involve levels of transcripts, methylation, and peptide
Swapnali Barde, Joëlle Rüegg, Josée Prud’homme, et al.
Proceedings of the National Academy of Sciences (2016) Vol. 113, Iss. 52
Open Access | Times Cited: 52
Behavioural biomarkers and mobile mental health: a new paradigm
Diego Hidalgo‐Mazzei, Allan H. Young, Eduard Vieta, et al.
International Journal of Bipolar Disorders (2018) Vol. 6, Iss. 1
Open Access | Times Cited: 48
The Role of Biomarkers in Psychiatry
Madia Lozupone, Maddalena La Montagna, Francesca D’Urso, et al.
Advances in experimental medicine and biology (2019), pp. 135-162
Closed Access | Times Cited: 46
Page 1 - Next Page

Scroll to top